Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing glimepiride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Glimepiride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Glimepiride 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Glimepiride 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing glimepiride and rosiglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing glimepiride and pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
|
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Glimepiride 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 3 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Glimepiride 3 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 2 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride- and rosiglitazone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing glimepiride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride and pioglitazone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing only glimepiride and rosiglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride and pioglitazone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride and rosiglitazone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing only glimepiride in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely glimepiride 4 milligram and rosiglitazone 8 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 4 milligram and rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 2 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 1 mg and rosiglitazone (as rosiglitazone maleate) 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely glimepiride 2 milligram and rosiglitazone (as rosiglitazone maleate) 8 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |
Glimepiride 4 mg and rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Glimepiride (substance) |
Inferred relationship |
Some |
1 |